Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Rapiblyk (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
November 27th 2024 -- AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA)...
FDA Approves Imkeldi (imatinib) Oral Solution for the Treatment of Certain Forms of Leukemia and Other Cancers
November 25, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the FDA has approved...
FDA Approves Attruby (acoramidis) to Reduce Cardiovascular Death and Cardiovascular-Related Hospitalization in Patients with ATTR-CM
PALO ALTO, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio or the Company), a new type of biopharmaceutical...
Monthly News Roundup - November 2024
Bimzelx Indications Expanded to Include Hidradenitis Suppurativa, a Debilitating Skin Condition UCB’s Bimzelx (bimekizumab-bkzx) has been granted...
Premature Birth Could Impact Life Span for Decades
Premature babies not only face serious and immediate health consequences: New research shows they are also more likely to die early, a risk that persists...
Drinking Lots of Water Really Is Good for You, Study Finds
The collected evidence is in, and drinking about eight cups of water per day is, in fact, good for you. So says a University of California San Francisco...
Most Americans Don't Know Alcohol's Links to Cancer
FRIDAY, Nov. 29, 2024 — Less than half of Americans realize that they're increasing their risk of cancer with every beer, cocktail or shot of whiskey. Despite...
Kids From Poorer Homes May Have Worse Outcomes If MS Strikes
A child from a poorer neighborhood is more prone to severe illness once they develop multiple sclerosis (MS) compared to children growing up in more affluent...
Some HRT Pills May Pose Special Risk for Blood Clots
Certain hormone replacement therapy pills appear to increase the risk of heart disease and serious blood clots in women going through menopause, a new...
Community-Level Social, Environmental Factors Tied to Mild Cognitive Impairment
Several community-wide social and environmental factors are associated with the onset of mild cognitive impairment (MCI) in older dementia-free individuals,...
2021 to 2022 Saw Decline in Abortions in the United States
From 2021 to 2022, there was a decrease in the number of abortions performed, as well as in the abortion rate and ratio, according to research published...
Family History of Mental Illness Tied to Aggression in Those With CTE
Chronic traumatic encephalopathy (CTE) pathology influences the effect of first-degree family history of mental illness (1°FHMI) on aggression among...
FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (elivaldogene autotemcel)
Since approval, the Food and Drug Administration (FDA) has received additional reports of hematologic malignancies, including life-threatening cases of...
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced...
Newer Epilepsy Medications Used During Pregnancy Do Not Affect Neurological Development in Children
Children of mothers who took certain antiseizure medications while pregnant do not have worse neurodevelopmental outcomes at age 6, according to a long-running...
Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007
Lin BioScience (6696. Taiwan OTC), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting acute...
Recently Added
Recently added consumer and prescribing information: Revuforj, Danziten, Aucatzyl, Emrosi, Imuldosa, Hympavzi, Flyrcado, Otulfi, Tecentriq Hybreza, Pavblu
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Rapiblyk Rapiblyk (landiolol) is an ultra-short acting cardioselective beta-1 adrenergic blocker for for the short-term reduction of ventricular...
- Imkeldi Imkeldi (imatinib mesylate) is an oral liquid formulation of the approved kinase inhibitor imatinib used for the treatment of certain forms...
- Attruby Attruby (acoramidis) is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...